BAC
Bank of America Corporation
BAC has the edge over ETOR overall, supported by stronger fundamentals and lower modeled downside.
ETOR
eToro Group Ltd.
ETOR offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ETOR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
ETOR's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like ETOR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
ETOR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 8.3x | $22.46 | — |
| Forward | 10x | $22.46 | — |
| Cheap | 12x | $31.64 | +41% |
| Fair | 15x | $39.69 | +77% |
| Expensive | 17x | $45.36 | +102% |
Historical ranges are pointers, not guarantees.
ETOR has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ETOR on the outlook, with more favorable valuation and earnings expectations.
ETOR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect ETOR's earnings, revenue and profitability to hold roughly steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ETOR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.15 | -21% |
| Q2 2026 | $2.71 | +22% |
| Q1 2026 | $2.44 | +6.6% |
| Q4 2025 | $2.30 | -1.7% |
ETOR has the edge over BAC in the latest year-over-year earnings comparison.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ETOR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over ETOR on profitability, with a higher operating margin.
ETOR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $239.5M | -89% |
| Q1 2026 | $268M | -93% |
| Q4 2025 | $3.9B | -34% |
| Q3 2025 | $4.1B | +164% |
| Q2 2025 | $2.1B | +13% |
| Q1 2025 | $3.8B | +11% |
ETOR's revenue has slid since its 2024 peak: $240M last quarter, down 89% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 27% | +25 points |
| Q1 2026 | 37% | +35 points |
| Q4 2025 | 2.2% | +0.5 points |
| Q3 2025 | 1.8% | -1.5 points |
| Q2 2025 | 2% | -0.3 points |
| Q1 2025 | 2% | -0.4 points |
| Q4 2024 | 1.7% | N/A |
| Q3 2024 | 3.2% | N/A |
ETOR's operating margin was 27% last quarter, up 25 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ETOR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $37.3M | -38% |
| Q1 2026 | $102.2M | +8.4% |
| Q4 2025 | $123.9M | +90% |
| Q3 2025 | $39.9M | -50% |
| Q2 2025 | $59.9M | -17% |
| Q1 2025 | $94.2M | +92% |
ETOR's free cash flow was $303M over the past year, up 1.5% from the year before. Free cash flow isn't a meaningful measure for financial services companies like ETOR.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ETOR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.6% | -2.5M shares |
| 1 year | -5.5% | -5.3M shares |
ETOR has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $88M |
| Q1 2026 | $101.1M |
| Q4 2025 | — |
| Q3 2025 | $875,000 |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ETOR spent $190M buying back its own shares over the past year, after none the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ETOR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.7x | Net Cash |
| Q1 2026 | -3.1x | Net Cash |
| Q4 2025 | -3.2x | Net Cash |
| Q3 2025 | -3.1x | Net Cash |
| Q2 2025 | -3.2x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -11.9x | Net Cash |
ETOR has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ETOR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.6 | Oversold |
| Stochastic | 5.7 | Oversold |
ETOR's weekly RSI is 30 (oversold) and its Stochastic is 6 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ETOR PE vs Financial Services Sector
| Metric | ETOR | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 36% below |
| PE % | 0 | 15 | 15 pts below |
ETOR has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has stronger trend alignment. BAC is above 1 of 5 weekly averages versus ETOR above 0 of 3.
ETOR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.3 | 7.4% below |
| 20 week MA | $29.9 | 25% below |
| 50 week MA | $32.8 | 31% below |
ETOR is in a downtrend: it's below all three of its weekly moving averages, and 31% below its 50-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over ETOR on returns for 2026, with the stronger performance.
ETOR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $64.2 | $35.9 | -44% |
| 2026 YTD | $35.9 | $22.5 | -37% |
ETOR has finished every year since 2025 lower, and it's down 37% so far in 2026.